Detalles de la búsqueda
1.
Benefit and toxicity of programmed death-1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study.
Br J Dermatol
; 187(3): 401-410, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35293617
2.
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).
Cancer
; 123(14): 2688-2697, 2017 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28334439
3.
Immune-Related Adverse Events in the Setting of PD-1/L1 Inhibitor Combination Therapy.
Oncologist
; 25(3): e398-e404, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162817
4.
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.
J Immunother Cancer
; 12(4)2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38599660
5.
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0.
J Immunother Cancer
; 11(10)2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37852736
6.
Side effects in melanoma patients receiving adjuvant interferon alfa-2b therapy: a nurse's perspective.
Support Care Cancer
; 20(8): 1601-11, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22562583
7.
Urgent access to a specialty care melanoma clinic is associated with a higher rate of melanoma detection.
J Am Acad Dermatol
; 64(6): 1060-7, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21453985
8.
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer.
J Immunother Cancer
; 9(8)2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34389617
9.
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 Monotherapy.
Clin Cancer Res
; 27(21): 5993-6000, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34376536
10.
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors.
J Immunother Cancer
; 9(7)2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34281989
11.
Immune Checkpoint Inhibitor-Based Therapy as a Backbone in Cancer Treatment.
J Adv Pract Oncol
; 11(3): 231-233, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33598316
12.
Your patient with melanoma: staging, prognosis, and treatment.
Oncology (Williston Park)
; 23(8 Suppl): 13-21, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19860037
13.
Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care.
J Adv Pract Oncol
; 10(Suppl 1): 9-20, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33014514
14.
Caring for Patients Treated With Checkpoint Inhibitors for the Treatment of Metastatic Merkel Cell Carcinoma.
Semin Oncol Nurs
; 35(5): 150924, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31514991
15.
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0
J. immunotherap. cancer
; 11(10): 1-39, 20231001. tab
Artículo
en Inglés
| BIGG | ID: biblio-1525933
16.
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0.
J Immunother Cancer
; 6(1): 44, 2018 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29848375
17.
Advances in Melanoma: The Rationale for the Melanoma Nursing Initiativeâ©.
Clin J Oncol Nurs
; 21(4 Suppl): 7-10, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28738056
18.
MAPK Pathway-Targeted Therapies: Care and Management of Unique Toxicities in Patients With Advanced Melanomaâ©.
Clin J Oncol Nurs
; 21(6): 699-709, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29149136
19.
PD-1 Inhibitor Therapy: Consensus Statement From the Faculty of the Melanoma Nursing Initiative on Managing Adverse Eventsâ©.
Clin J Oncol Nurs
; 21(4 Suppl): 42-51, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28738055
20.
Immunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunity.
Clin Cancer Res
; 11(21): 7692-9, 2005 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16278389